Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.71% | 203.21 | 1.3% | $436.19m | |
| BIIB | Biogen Inc. | 0.73% | 227.72 | 1.3% | $386.27m | |
| GILD | Gilead Sciences, Inc. | 0.08% | 65.35 | 0.9% | $368.51m | |
| CELG | Celgene Corporation | 0.02% | 100.97 | 1.3% | $353.70m | |
| ILMN | Illumina, Inc. | -0.80% | 309.67 | 3.5% | $257.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.46% | 299.40 | 2.6% | $220.44m | |
| EXAS | Exact Sciences Corporation | -2.17% | 97.58 | 24.1% | $205.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -5.06% | 99.51 | 2.0% | $180.57m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.03% | 176.09 | 1.9% | $177.48m | |
| A | Agilent Technologies, Inc. | -0.65% | 75.26 | 1.6% | $148.26m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.49% | 86.74 | 14.6% | $140.12m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.83% | 67.94 | 4.3% | $95.23m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.05% | 18.87 | 10.2% | $90.77m | |
| SGEN | Seattle Genetics, Inc. | 0.58% | 83.86 | 6.2% | $87.50m | |
| NKTR | Nektar Therapeutics | 1.42% | 17.54 | 5.5% | $85.01m |
Company Profile
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.